167 related articles for article (PubMed ID: 25126591)
61. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.
Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A
Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550
[TBL] [Abstract][Full Text] [Related]
62. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies.
Ross JS; Ali SM; Wang K; Palmer G; Yelensky R; Lipson D; Miller VA; Zajchowski D; Shawver LK; Stephens PJ
Gynecol Oncol; 2013 Sep; 130(3):554-9. PubMed ID: 23791828
[TBL] [Abstract][Full Text] [Related]
63. Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.
Kuijjer ML; van den Akker BE; Hilhorst R; Mommersteeg M; Buddingh EP; Serra M; Bürger H; Hogendoorn PC; Cleton-Jansen AM
BMC Med Genomics; 2014 Jan; 7():4. PubMed ID: 24447333
[TBL] [Abstract][Full Text] [Related]
64. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
[TBL] [Abstract][Full Text] [Related]
65. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
66. Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma.
Zhang HQ; Li MH; Gao P; Lan PH; Fan B; Xiao X; Lu YJ; Chen GJ; Wang Z
Orthop Surg; 2016 May; 8(2):129-38. PubMed ID: 27384721
[TBL] [Abstract][Full Text] [Related]
67. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
[TBL] [Abstract][Full Text] [Related]
68. Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer.
Gong Y; Fan L; Fei X; Zhu Y; Du X; He Y; Pan J; Dong B; Xue W
J Urol; 2021 Aug; 206(2):279-288. PubMed ID: 33780283
[TBL] [Abstract][Full Text] [Related]
69. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
70. Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations.
Yang J; Wang X; Lu J; Chen H; Zhao X; Gao C; Bai Y; Zhang Q; Fu X; Zhang X
J Cancer; 2021; 12(17):5099-5105. PubMed ID: 34335926
[TBL] [Abstract][Full Text] [Related]
71. A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling service.
Russell K; Shunyakov L; Dicke KA; Maney T; Voss A
Front Pharmacol; 2014; 5():76. PubMed ID: 24782778
[TBL] [Abstract][Full Text] [Related]
72. Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis.
Ellis L; Lehet K; Ku S; Azabdaftari G; Pili R
Oncoscience; 2014 Oct; 1(10):609-613. PubMed ID: 25485289
[TBL] [Abstract][Full Text] [Related]
73. Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrations.
Silva JG; Corrales-Medina FF; Maher OM; Tannir N; Huh WW; Rytting ME; Subbiah V
Oncoscience; 2015; 2(2):187-92. PubMed ID: 25859559
[TBL] [Abstract][Full Text] [Related]
74. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.
Cao Y; Roth M; Piperdi S; Montoya K; Sowers R; Rao P; Geller D; Houghton P; Kolb EA; Gill J; Gorlick R
PLoS One; 2014; 9(8):e106249. PubMed ID: 25170759
[TBL] [Abstract][Full Text] [Related]
75. Activity of pazopanib in
Gouda MA; Zarzour MA; Vaporciyan AA; Kairemo K; Chuang HH; Subbiah V
Oncoscience; 2023; 10():44-53. PubMed ID: 37736255
[TBL] [Abstract][Full Text] [Related]
76. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.
Candido MF; Medeiros M; Veronez LC; Bastos D; Oliveira KL; Pezuk JA; Valera ET; Brassesco MS
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839989
[TBL] [Abstract][Full Text] [Related]
77. Dieckol exerts anticancer activity in human osteosarcoma (MG-63) cells through the inhibition of PI3K/AKT/mTOR signaling pathway.
Zhang S; Ren H; Sun H; Cao S
Saudi J Biol Sci; 2021 Sep; 28(9):4908-4915. PubMed ID: 34466065
[TBL] [Abstract][Full Text] [Related]
78. Precision Medicine in Osteosarcoma: MATCH Trial and Beyond.
Tirtei E; Campello A; Asaftei SD; Mareschi K; Cereda M; Fagioli F
Cells; 2021 Jan; 10(2):. PubMed ID: 33572496
[TBL] [Abstract][Full Text] [Related]
79. A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma.
Somarelli JA; Rupprecht G; Altunel E; Flamant EM; Rao S; Sivaraj D; Lazarides AL; Hoskinson SM; Sheth MU; Cheng S; Kim SY; Ware KE; Agarwal A; Cullen MM; Selmic LE; Everitt JI; McCall SJ; Eward C; Eward WC; Hsu DS
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187254
[TBL] [Abstract][Full Text] [Related]
80. Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors.
Scotlandi K; Hattinger CM; Pellegrini E; Gambarotti M; Serra M
Cells; 2020 Apr; 9(4):. PubMed ID: 32295254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
